Nanomedicine As a Strategy to Fight Thrombotic Diseases | Zendy

Mariana Varna | Zendy; Maya Juenet | Zendy; Richard Bayles | Zendy; Mikaël Mazighi | Zendy; Cédric Chauvierre | Zendy; Didier Letourneur | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Nanomedicine As a Strategy to Fight Thrombotic Diseases

Author(s) -

Mariana Varna,

Maya Juenet,

Richard Bayles,

Mikaël Mazighi,

Cédric Chauvierre,

Didier Letourneur

Publication year - 2015

Publication title -

future science oa

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.825

H-Index - 23

ISSN - 2056-5623

DOI - 10.4155/fso.15.46

Subject(s) - medicine , thrombolysis , nanocarriers , nanomedicine , thrombolytic drug , drug , clinical trial , pharmacology , thrombosis , drug delivery , clinical research , stroke (engine) , intensive care medicine , myocardial infarction , nanotechnology , mechanical engineering , materials science , nanoparticle , engineering

This review highlights the preclinical and clinical research based on the use of nano- and micro-carriers in thrombolytic drug delivery. Ischemic heart and stroke caused by thrombosis are the main causes of death in the world. Because of their inactivation in the blood, high doses of thrombolytics are administered to patients, increasing the risk of intracranial hemorrhage. Preclinical research conducted with lipid, polymer or magnetic nanoparticles loaded with thrombolytic drugs showed an enhancement of thrombolysis and a reduction of undesirable side effects. Targeted nanocarriers exhibited an increased accumulation into clot. Clinical trials were already conducted with lipid-based microbubbles combined with ultrasound and thrombolytic drug and showed thrombolysis improvement. Future validation of nanosystems is awaited in clinic. This research opens new strategies for the management of thrombotic diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research